Insulin glargine and lixisenatide Subcutaneous and Sitagliptin and simvastatin
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Sitagliptin and simvastatin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: simvastatin / sitagliptin
Brand name: Juvisync
Synonyms: Sitagliptin and simvastatin (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Sitagliptin Phosphate
- Insulin glargine and lixisenatide Subcutaneous-Sitavig
- Insulin glargine and lixisenatide Subcutaneous-Sivextro
- Insulin glargine and lixisenatide Subcutaneous-Sivextro (Tedizolid Injection)
- Insulin glargine and lixisenatide Subcutaneous-Sivextro (Tedizolid Tablets)
- Insulin glargine and lixisenatide Subcutaneous-Sivextro Intravenous
- Sitagliptin and simvastatin-Insulin glargine, recombinant Subcutaneous
- Sitagliptin and simvastatin-Insulin glulisine
- Sitagliptin and simvastatin-Insulin Glulisine (Cartridges and Pens)
- Sitagliptin and simvastatin-Insulin Glulisine (Vials)
- Sitagliptin and simvastatin-Insulin glulisine Subcutaneous
- Sitagliptin and simvastatin-Insulin human inhaled Inhalation